BridgeMD
New treatment option for Health Behavior
Official title Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
ClinicalTrials.gov ID: NCT07245420
What this study is testing
- What it's testing
- Childhood cancer survivors who received certain treatments are at a higher risk of developing heart problems in the future. This study is looking at ways to educate childhood cancer survivors about that risk and encourage them to receive a recommended heart screening test.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 26 and older
You may be able to join if
- Childhood Cancer Survivor Study (CCSS) Participants
- Age ≥26 years
- Treated with cumulative doxorubicin equivalent anthracycline doses ≥100 mg/m2 with any/no radiation, or ≥15 Gy chest radiation with any/no...
- No history of cardiomyopathy
- Has not had an echocardiogram in the previous 5 years
You likely can't join if
- Currently participating in a long-term follow-up program that provides risk-based screening
See the full eligibility criteria
- Childhood Cancer Survivor Study (CCSS) Participants
- Age ≥26 years
- Treated with cumulative doxorubicin equivalent anthracycline doses ≥100 mg/m2 with any/no radiation, or ≥15 Gy chest radiation with any/no anthracyclines
- No history of cardiomyopathy
- Has not had an echocardiogram in the previous 5 years
- Has a history of successful completion of CCSS surveys
- English-Speaking
- Has not been enrolled in ECHOS-1 (pilot)
- Currently participating in a long-term follow-up program that provides risk-based screening
The study team makes the final eligibility decision.
Where it's taking place
- Memphis, Tennessee, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 26 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Memphis, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.